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We describe a new rapid and eﬃcient polymerase chain reaction (PCR)-based site-directed mutagenesis method. This procedure
is eﬀective with any plasmid and it employs four oligonucleotide primers. One primer contains the desired mutation, the second
is oriented in the opposite direction (one of these two primers should be phosphorylated), and the third and fourth should be
coding in complementary fashion for a unique restriction site to be introduced in a nonessential region. The method consists of
two simultaneous PCR reactions; the PCR products are digested with the enzyme that recognizes the newly introduced unique
restriction site and then ligased and used to transform competent bacteria. Additionally, the use of Dpn I facilitates the elimination
of template DNA. The newly introduced restriction site is essential for ligation in the correct orientation of the two-PCR products
and is further used for mutant screening. Resulting plasmids carry both the new restriction site and the desired mutation. Using
this method, more than 20 mutants have already been generated (using two diﬀerent kinds of templates); all these mutants were
sequenced for the desired mutation and transfected into AtT-20 cells and the expressed mutant proteins encoded by the vector were
assayed.
INTRODUCTION
Site-directed mutagenesis is an important procedure
in studies of gene expression and protein structure-
function relationships. Several protocols have been devel-
oped to mutate specific sequences in plasmid DNA. All
employ oligonucleotide primers containing the desired
mutations flanked by bases complementary to target se-
quences [1]. Primers are extended in vitro, although some
procedures have described in vivo extension after trans-
formation of special host bacteria [2].
Polymerase chain reaction (PCR) is a method of am-
plifying a segment of DNA; the advent of PCR has al-
lowed the introduction of site-specific mutations into
DNA by the incorporation of the desired mutations into
the oligonucleotide primers. It has become possible to
amplify longer sequences (up to 6 kilo base (kb)), and
the use of diﬀerent thermostable DNA polymerases with
3′ → 5′ exonuclease “proofreading” activity allowed to re-
duce to very few unwanted mutations. Numerous PCR-
based methods of site-directed mutagenesis have been de-
veloped such as the generation of a mutant fragment,
which has to be subcloned in the same vector used as
a template [3, 4]. The overlap extension PCR method,
that requires a large number of primers [5], and the
megaprimer one that uses several rounds of PCR [6, 7]
have been reported. These require a well-designed strat-
egy taking into account the length of the mutated frag-
ment, the presence of (two) unique cleavage sites, and the
purification of PCR intermediate products used as tem-
plates for further PCR reaction rounds (for review see
[8]).
In this paper, we describe a new method that allows
the rapid generation of desired mutant with a high eﬃ-
ciency once the gene of interest has been cloned in a vec-
tor. The method consists of two simultaneous PCR reac-
tions. The resulting products possess a new unique re-
striction site on one end and one of them is phospho-
rylated on the other end. We have used this methodol-
ogy to amplify two halves of the pLNCX2 vector contain-
ing human prorenin or prosomatostatin. We have gener-
ated more than 20 mutants with diﬀerent types of mu-
tations: single-point mutations, deletions, or insertions.
All the performed mutants were sequenced for the de-
sired mutation in the corresponding insert. Subsequently,
they were stably transfected in AtT-20 cells and the ex-
pressed mutant proteins encoded by the vector were as-
sayed.
MATERIALS ANDMETHODS
This method consists in amplifying by PCR the two
halves of a plasmid using four primers, of which one or
two contain the desired mutation(s) and two are comple-
mentary coding for an additional unique restriction site
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Figure 1. Schematic representation of site-directed mutagene-
sis strategy: primer M′ contains the desired mutation∗, primer
M oriented in the opposite direction is phosphorilated, and the
primers S and S′ are complementary and code for newly intro-
duced unique restriction site BamH I (urs). The two-PCR prod-
ucts are digested with BamH I and ligased. AfterDpn I digestion,
the circular DNA carry the desired mutation.
(Figure 1). The gene of interest (either prosomatostatin
or prorenin) was cloned into pLNCX2 vector in Xho I site
(Clontech, Basel, Switzerland) according to standard pro-
cedures. Then, two pairs of primers (Mx/S versus M′x/S′)
were designed in order to amplify either the “right” or the
“left” half of the plasmid.
M1: 5′P-GGTGCCATAGCCGGGTT3′,
M2: 5′P-GGGAGCGCCGGTGACACAGCC3′,
M3: 5′P-TCTCTGCAGCTCAAGCCTCAT3′,
M′1: 5′CCGAGAAAAGAAAGCTGGCTGCAAG3′,
M′2: 5′GCTGCTGCCGCGGGGAAGCAG3′,
M′3: 5′AGGCCTCCAGGTTTTTCACCTTTCCGATG
ATCTGCTAACTCAAACCC3′
S: 5′GTCTTCAAGGATCCATACCAG3′
S′: 5′CTGGTATGGATCCTTGAAGAC3′.
A mutagenic phosophorylated primer M′, comple-
mentary to the insert, carries the desired mutation and
is coupled to S′. A primer “back-to-back” M of the mu-
tagenic primer is coupled to the second selection primer
S; this one could carry an additional mutation if desired.
The 5′ ends of the two mutagenic primers meet, but do
not overlap.
The “selection” primers called S and S′ are designed
to change a nonessential restriction site EcoR I of the plas-
mid to BamH I, a restriction site that does not exist nei-
ther in the vector nor in the insert. PCR reactions are then
performed with a proofreading thermostable DNA poly-
merase to avoid unwanted mutations. DNA polymerase
(Pfu Turbo or Pfu) was purchased from Stratagene (Eu-
rope) or from Promega (Wallisellen, Switzerland). The
primers M1/M′1, M2/M′2, and M3/M′3 were used to
perform single mutation, deletion, and insertion, respec-
tively.
The reaction mixture (100µL) contains 100ng of the
native plasmid, 20 pmol of each primer, 10 nM of each
dNTP (Roche, Rotkreuz, Switzerland), and 3U of the Pfu
polymerase (Stratagene, Europe or Promega, Wallisellen,
Switzerland) in 1x Pfu buﬀer. This mixture is then sub-
jected to a thermal cycling on a thermalcycler (Tgradient
from Biometra, Switzerland) at 95◦C for 30 second for
denaturation, followed by 30 second for annealing (the
temperature depends on the pair of primers) and then
for 6 minutes at 72◦C for extension. A total of 12 cycles
was used and the procedure was ended by 10 minutes ex-
tension at 72◦C. The reaction products are analyzed di-
rectly by electrophoresis in a 1% agarose gel. Complemen-
tary PCR fragments were copurified on Microcon PCR
(Amicon, Millipore, Bedford, Mass, USA) and eluted
in 20µL of ultrapure H2O. Ten µL are then digested for
2 hours at 37◦C by BamH I; this reaction is purified by
a passage through Microcon-PCR centrifugal filter device
and eluted into 20µL of ultrapure H2O. An aliquot of
4µL is incubated with T4 DNA ligase (2.5µL of 10x ligase
buﬀer, 2.5µL (7.5U) of enzyme, and 16µL of H2O) over
night at room temperature (2 hour incubation at 37◦C
could be suﬃcient but for practical reasons over night in-
cubation was used). The ligation reaction is then digested
for 2 hours at 37◦C with Dpn I (Promega) (to the 25µL of
ligase reaction, we added 8µL of 10x buﬀer, 45µL of H2O,
and 2µL (20U) of enzyme) in order to eliminate the wild-
type template. Ten µL of this mixture is used to transform
XL1-blue E. Coli bacteria. For transformation assay, com-
petent cells (100µL) were incubated with 10µL of reac-
tion mixture for 30 minutes at 4◦C, the cells were heat
shocked for 45 second at 42◦C. The transformation mix-
ture was diluted four-fold with SOC medium and grown
for one hour at 37◦C. The transformed bacteria are plated
on LB 80µg/mL ampicillin-containing plates and grown
over night at 37◦C.
RESULTS
The four PCR primers S, S′, M, and M′ (in Figure 1)
were used in one round of two independent PCR. Primer
M′ had the desired mutation. The segment α was ampli-
fied in one PCR reaction using primers S (containing the
unique restriction site) and M in the presence of template
DNA pLNCX2 containing prosomatostatin or prorenin.
In order to avoid possible PCR-induced errors, only 12 cy-
cles of PCR are performed using rather large amounts of
template DNA (100ng). Primers S′ and M′ were used to
amplify the fragment β. The PCR products were analyzed
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Figure 2. PCR products generated from pLNCX2-SOM and
their ligation followed with Dpn I treatment. Lane 1: fragment
α, lane 2: fragment β, lane 3: fragment α and β ligased, lane 4:
ligation andDpn I treatment, and lane 5: marker X (Roche diag-
nostics, Mannheim, Germany). DNA samples were fractionated
in 1% agarose gel and stained with ethidium bromide.
on agarose gel and yielded the expected DNA molecu-
lar weight, 3 kb for fragment α and 3.5 kb for fragment
β of the pLNCX2-prosomatostatin vector (Figure 2, lanes
1 and 2). The fragments α and β exhibit the same unique
restriction site (BamH I), at the 5′ end for α and at the
3′ end for β, which in addition is phosphorylated at its
5′ end. These two introduced modifications after diges-
tion with BamH I allowed a correct segment orientation
for the vector construction carrying the desired mutation
with the newly introduced restriction site. Figure 2 (lane
3) demonstrates an eﬃcient ligation with almost all PCR-
generated DNA conversion into larger molecular weight
DNA. The remaining template DNA was eliminated by
Dpn I digestion (Figure 2, Lane 4).
After DNA bacterial transformation, ampicillin-
resistant individual colonies were grown over night at
37◦C in LB broth containing (80µg/mL) ampicillin. Plas-
mid DNA was prepared by alkaline lysis using conven-
tional methods and treated with BamH I or EcoR I for
mutants screening (Figure 3). Because the BamH I site re-
placed one of the two pLNCX2 EcoR I sites, digestion by
BamH I or EcoR I linearized the obtained mutants (in-
stead of generation of two bands in the wild type). BamH
I-resistant colonies represent residual DNA template after
Dpn I treatment, which is confirmed by EcoR I treatment
(Figure 3).
Larger amount of DNA of one of these mutants
was prepared by Midipreps (Wizard plus, Promega, Wal-
lisellen, Switzerland), the obtained DNAwas sequenced to
confirm the presence of desired mutations and to exclude
the possible unwanted mutations. The DNA was then
transfected into AtT20 cells. With this protocol, we have
generated 20 mutations on two diﬀerent inserts cloned
into pLNCX2 (Clontech). Within a few weeks, 10 muta-
tions were successfully produced on prosomatostatin (7
single-point mutations, 1 insertion, and 2 deletions); 7
mutations used the prosomatostatin wild type as a tem-
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Figure 3. Minipreps analysis for mutant screening: clone 4 gen-
erates a 1.6-kb DNA fragment with EcoR I and is resistant to
BamH I digestion. It may represent residual DNA after Dpn
I digestion. Lane5: marker X (Roche diagnostics, Mannheim,
Germany). DNA samples were fractionated in 1% agarose gel,
stained with ethidium bromide.
plate and 3 used one of the first mutants as a template. For
prosomatostatin primers, M1 and M′1 were used to per-
form a single mutation (Arg→ Lys),M2 andM′2 to delete
13 amino acids in proregion, and M3 and M′3 allowed
the insertion of bradykinin sequence at C-terminus re-
gion to substitute somatostatin-28 coding sequence (Fig-
ures 4 and 5). Within the same time frame, another 12
mutations on prorenin (11 were single-point mutations
and one deletion) were carried out; 7 used prorenin wild
type as a template and 5 used again these first mutants as
templates. For the second set of mutants, the unique re-
striction siteMlu I was used.
DISCUSSION
This newmutagenesis method allows performingmu-
tations more eﬃciently in less time than with traditional
methods. Moreover, it is possible to achieve many types
of mutation, for example, insertions, single-point mu-
tations, and deletions, depending on the design of the
primers. Figure 5 shows an example of deletion and in-
sertion created in human prosomatostatin cDNA. In ad-
dition, the first generated mutant can be used as a tem-
plate for a second round of mutations as long as it is
possible to introduce an additional unique restriction site
that is required for a correct vector reconstruction and
mutant screening. Indeed, this can even be taken further
by using such a second mutant as a template for a third
round of mutation, and in that case, the first primers (S
and S′) with the unique restriction site BamH I could be
reused.
The method is rapid and can generate an abundance
of mutated segments; once the PCR is carried out, the
following steps are straightforward manipulations. This
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S’  5’ 
CAGAAGTTCCTAGGTATGGTC 
  AGGCGTATCACGAGGCCCTTTCGTCTTCAAGAATTCATACCAGATCACCGAAAACTGTCCTCCAATGTGTCCCCC 
  TCCGCATAGTGCTCCGGGAAAGCAGAAGTTCTTAAGTATGGTCTAGTGGCTTTTGACAGGAGGTTACACAGGGGG 
GTCTTCAAGGATCCATACCAG> 
  5’  S 
 
  5’ M’1 
  CCGAGAAAAGAAAGCTGGCTGCAAG> 
  ACGTCTCTAGACGATTGAGTTTGGGCCGATACCGTGGGGCTCTTGCGTTTCGACCGACGTTCTTAAAGAAGACCT 
  TGCAGAGATCTGCTAACTCAAACCCGGCTATGGCACCCCGAGAACGCAAAGCTGGCTGCAAGAATTTCTTCTGGA 
<TTGGGCCGATACCGTGG-P 
  M1       5’ 
S’  5’ 
 <CAGAAGTTCCTAGGTATGGTC 
  AAAAATAGGCGTATCACGAGGCCCTTTCGTCTTCAAGAATTCATACCAGATCACCGAAAACTGTCCTCCAATGTGTCCCCCTCACACTC 
  TTTTTATCCGCATAGTGCTCCGGGAAAGCAGAAGTTCTTAAGTATGGTCTAGTGGCTTTTGACAGGAGGTTACACAGGGGGAGTGTGAG 
    GTCTTCAAGGATCCATACCAG> 
    5’  S 
 
   M2               5’ 
         <CCGACACAGTGGCCGCGAGGG-P 
  GTCCCCTGGGCTGTGTCACCGGCGCTCCCTCGGACCCCAGACTCCGTCAGTTTCTGCAGAAGTCCCTGGCTGCTGCCGCGGGGAAGCAG 
  CAGGGGACCCGACACAGTGGCCGCGAGGGAGCCTGGGGTCTGAGGCAGTCAAAGACGTCTTCAGGGACCGACGACGGCGCCCCTTCGTC 
 GCTGCTGCCGCGGGGAAGCAG> 
 5’  M’2 
S’  5’ 
  <CAGAAGTTCCTAGGTATGGTC 
  AGGCGTATCACGAGGCCCTTTCGTCTTCAAGAATTCATACCAGATCACCGAAAACTGTCCTCCAATGTGTCCCCC 
  TCCGCATAGTGCTCCGGGAAAGCAGAAGTTCTTAAGTATGGTCTAGTGGCTTTTGACAGGAGGTTACACAGGGGG 
  GTCTTCAAGGATCCATACCAG> 
  5’    S 
 
    M3    5’ 
    <TACTCCGAACTCGACGTCTCT-P 
GCTGCTGAGCAGGATGAAATGAGGCTTGAGCTGCAGAGATCTGCTAACTCAAACCCGGCTATGGCACCCCGAGAA 
CGACGACTCGTCCTACTTTACTCCGAACTCGACGTCTCTAGACGATTGAGTTTGGGCCGATACCGTGGGGCTCTT 
  TCTGCTAACTCAAACCC> 
  AGGCCTCCAGGTTTTTCACCTTTCCGATGA  
 5’ M’3 
Figure 4. Schematic representation of the used vector and primers design to perform the three diﬀerent kinds of mutations. M1/M′1
for single mutation, M2/M′2 for deletion, M3/M′3 for insertion, and S1 and S′1 are the mutagenesis common primers.
method is as eﬃcient as the method that uses a single
inverted PCR with two primers to generate a full-length
mutant plasmid [5, 6]. In addition, the present method
has several other advantages. It allows the introduction of
multiple-distant mutations (up to 55 bp, depending on
the maximum length of the primers), as long as the 5′
ends of the two mutagenic primers (M and M′) meet and
as one or both primers carry the desired mutations. Al-
ternatively, since the 5′ end of the M′ and the 3′ end of
the complementary sequence of M (Figures 1 and 4) are
designed tomeet, any length of nucleotide sequence in be-
tween is deleted. The size of the deletion region depends
exclusively on the design of the primers used on the vec-
tor DNA sequence Figure 4. Furthermore, insertions can
also be made, theoretically, without limit in the size; the
M′ primer has to be designed that its 5′ end codes for the
sequence to be inserted and its 3′ end is complementary
to the successive sequence. We managed to insert 30 nu-
cleotides with this method (Figure 5B), but we did not use
any larger sequence.
Another important potential advantage of this
method is the rapid construction of chimera proteins. The
corresponding cDNA of the two diﬀerent proteins should
be cloned in the same vector (or two very similar vectors).
One PCR performed on the first plasmid will amplify the
5′ end of the first cDNA, and the second on the second
plasmid will amplify the 3′ end of the other cDNA. As for
other types of mutation, the primers should be designed
in order to keep the right reading frame. It is also possible
to combine the diﬀerent mutatgenic reactions and carry
out mutated chimeric proteins.
A straightforward success of this method requires
that the PCR fragment that contains the bacterial an-
tibiotic resistance and plasmid replication region (frag-
ment β) should not be phosphorylated. Otherwise, resid-
ual PCR products that are not completely digested (by
BamH I in our case) can close up during the ligation
reaction and transform bacteria, resulting in the pres-
ence of some clones on the LB Agar Petri, which con-
tain a short vector constituted only by a half of the
plasmid.
In conclusion, we have developed a new, highly
eﬃcient PCR-based site-directed mutagenesis method,
which allows for single mutation as well as double or mul-
tiple combined mutations including single-point muta-
tion, deletion, and insertion.
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Figure 5. Example of successful deletion and insertion. A: 13 residues were deleted from the N-terminus of human somatostatin
cDNA. B: 9 residues coding for bradykinin and a stop codon (30 nucleotides) were introduced at the C-terminus of somatostatin
precursor.
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